Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteinsManabu Fujimoto, Kazuhiko Takehara, Yasuhito Hamaguchi et al.|Arthritis & Rheumatism|2011Cited by 303
CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced SclerodermaAyumi Yoshizaki, Shinichi Sato, Yohei Iwata et al.|American Journal Of Pathology|2008Cited by 204
Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma ModelAyumi Yoshizaki, Shinichi Sato, Motoi Takenaka et al.|The Journal of Immunology|2010Cited by 139
Treatment with rapamycin prevents fibrosis in tight‐skin and bleomycin‐induced mouse models of systemic sclerosisAyumi Yoshizaki, Shinichi Sato, Koichi Yanaba et al.|Arthritis & Rheumatism|2010Cited by 126
Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle InvolvementK. Kaji, Masataka Kuwana, Noreen Fertig et al.|Arthritis Care & Research|2013Cited by 117